Ruiling Yuan, Hematologist/Oncologist at Self Regional Healthcare, Adjunct Assistant Professor at Edward Via College of Osteopathic Medicine and Medical University of South Carolina, shared on LinkedIn:
“Great to be at the 2026 Carolinas Cancer Conference today!
A very important and timely talk from Dr. Jonathan Ticku, on bringing bispecific antibody (BiTE) therapy into the community oncology setting.
The therapy may be ‘off the shelf,’ but building a safe and successful program takes much more: operational readiness, multidisciplinary education, toxicity recognition and management, and strong patient/caregiver education.
As more cutting-edge therapies become available, we need to continue building the infrastructure and expertise to deliver them safely closer to where our patients live. Access should not depend on a patient’s ZIP code.
Thank you, Jonathan Ticku, for such an excellent, practical, and inspiring presentation and for helping move community cancer care forward.
“One of the best parts of today’s 2026 Carolinas Cancer Conference SCOS/NCOA 2026: Fellows Jeopardy!
What a fun way to bring learning, teamwork, and a little friendly competition into the meeting. Great energy in the room and impressive knowledge from our fellows!
And of course, hosted by one of our favorites, Emily Touloukian, DO, thank you, Emily, for making oncology education so engaging and fun!
A great reminder that learning doesn’t always have to happen behind a podium.”
Other articles about BiTE on OncoDaily.
